amphotericin-b and Ape-Diseases

amphotericin-b has been researched along with Ape-Diseases* in 1 studies

Other Studies

1 other study(ies) available for amphotericin-b and Ape-Diseases

Article	Year
Visceral leishmaniasis in an infant gorilla (Gorilla gorilla gorilla): Clinical signs, diagnosis, and successful treatment with single-dose liposomal amphotericin B. Journal of medical primatology, 2018, Volume: 47, Issue:6 A 2-year-old captive gorilla (Gorilla gorilla gorilla) was diagnosed with visceral leishmaniasis in Brazil, and treated with a single dose of liposomal amphotericin B, which resulted in clinical cure. This is the first report of visceral leishmaniasis in gorillas, and the first reported liposomal amphotericin B treatment in great apes. Topics: Amphotericin B; Animals; Animals, Zoo; Antiprotozoal Agents; Ape Diseases; Brazil; Gorilla gorilla; Leishmaniasis, Visceral; Male	2018

Article

Year

Visceral leishmaniasis in an infant gorilla (Gorilla gorilla gorilla): Clinical signs, diagnosis, and successful treatment with single-dose liposomal amphotericin B.

Journal of medical primatology, 2018, Volume: 47, Issue:6

A 2-year-old captive gorilla (Gorilla gorilla gorilla) was diagnosed with visceral leishmaniasis in Brazil, and treated with a single dose of liposomal amphotericin B, which resulted in clinical cure. This is the first report of visceral leishmaniasis in gorillas, and the first reported liposomal amphotericin B treatment in great apes.

Topics: Amphotericin B; Animals; Animals, Zoo; Antiprotozoal Agents; Ape Diseases; Brazil; Gorilla gorilla; Leishmaniasis, Visceral; Male

2018